Exact Sciences
EXAS
#1154
Rank
C$26.77 B
Marketcap
C$141.08
Share price
-0.07%
Change (1 day)
60.70%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Cash on Hand

Cash on Hand as of September 2025 : C$1.40 Billion

According to Exact Sciences's latest financial reports the company has C$1.40 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Exact Sciences - Cash on Hand chart (from 2001 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$1.48 B44.42%
2023-12-31C$1.03 B20.26%
2022-12-31C$0.85 B-34.69%
2021-12-31C$1.31 B-44.02%
2020-12-31C$2.34 B455.01%
2019-12-31C$0.42 B-72.4%
2018-12-31C$1.53 B186.79%
2017-12-31C$0.53 B27.72%
2016-12-31C$0.41 B-1.79%
2015-12-31C$0.42 B29.73%
2014-12-31C$0.32 B131.32%
2013-12-31C$0.14 B31.94%
2012-12-31C$0.10 B13.21%
2011-12-31C$94.96 M-0.43%
2010-12-31C$95.37 M272.6%
2009-12-31C$25.59 M326.43%
2008-12-31C$6 M-52.19%
2007-12-31C$12.55 M-48.83%
2006-12-31C$24.53 M-38.23%
2005-12-31C$39.72 M-34.22%
2004-12-31C$60.39 M67.42%
2003-12-31C$36.07 M-47.91%
2002-12-31C$69.25 M-23.53%
2001-12-31C$90.55 M128.34%
2000-12-31C$39.65 M673.83%
1999-12-31C$5.12 M-62.23%
1998-12-31C$13.56 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Myriad Genetics
MYGN
C$0.20 B-85.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
C$0.51 B-63.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
C$9.25 M-99.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$14.59 B 941.97%๐Ÿ‡ซ๐Ÿ‡ท France